Global EditionASIA 中文双语Français
China
Home / China / Health

China launches huge COVID drugs study

By Cheng Si | chinadaily.com.cn | Updated: 2023-06-09 22:17
Share
Share - WeChat

China launched the first real-world study on COVID-19 listed drugs on Friday in Beijing.

Data from nearly 40,000 COVID-19 patients at more than 100 large hospitals and grassroots medical institutes across the nation’s 30 provinces and cities will be included in the study.

The study will focus on doctors’ diagnosis and treatment of COVID-19 patients, inputting their data and performing follow-up visits to realize whole-process management of the patients on digitalized platforms.

The study will offer more sound support to the safety and efficiency of COVID-19 drugs by including significant amounts of patient data, and will help verify the clinical applications of these drugs.

Also, the study will help conclude which treatment is most economical, both in clinical and pharmaceutical terms, by calculating the expenses incurred by treating these patients.

Zhou Wenting in Shanghai contributed to this story.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US